XNAS · Healthcare · Medical Instruments & Supplies
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Q1 2026 | 0.01 | 0.01 | +0.00% | $5.2M | ➖ Inline | -3.72% | +3.41% | +5.88% |
| 2026-03-12 | Q4 2025 | 0.01 | 0.01 | +0.00% | $4.7M | ➖ Inline | -5.26% | -22.37% | -22.11% |
| 2025-11-06 |
| Q3 2025 |
| -0.02 |
| 0.03 |
| +250.00% |
| $4.8M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-03-24 | Q4 2024 | -0.01 | 0.04 | +500.00% | $3.9M | ✅ Beat | +1.32% | +13.16% | +22.37% |
| 2024-11-07 | Q3 2024 | -0.02 | 0.02 | +200.00% | $3.5M | ✅ Beat | +3.87% | +1.94% | +5.81% |
| 2024-03-07 | Q4 2023 | -0.02 | -0.06 | -200.00% | $3.3M | ❌ Miss | — | — | — |
| 2023-11-08 | Q3 2023 | -0.06 | -0.02 | +66.67% | $3.7M | ✅ Beat | -2.59% | +3.14% | +9.12% |
| 2023-05-10 | Q1 2023 | -0.02 | -0.03 | -50.00% | $3.7M | ❌ Miss | -0.89% | -18.49% | +18.49% |
Showing last 8 quarters.